Aksel Siva (EAN Programme Committee; Professor of Neurology, Istanbul University, Cerrahpasa School of Medicine, Turkey) talks to us about various treatment considerations in multiple sclerosis (MS): induction, individualised therapy, optimal therapeutic window and when to switch therapies. Part 2 of 2.
1. Is there an optimum therapeutic window in MS? (0:12)
2. What factors influence your decision about switching therapies? (1:51)
View Part 1 here.
Speaker disclosure: Aksel Siva has nothing to disclose in relation to this video interview.
Filmed at the 4th Congress of the European Academy of Neurology (EAN), Lisbon, Portugal, June 2018.